Both Wegovy and Mounjaro are GLP-1 receptor agonists approved to help blood sugar , and can also support shedding pounds. However , Mounjaro possesses a combined mechanism of action, targeting both GLP-1 and GIP receptors, potentially leading to improved glycemic control and more significant slimming than copyright which mainly focuses on the GLP-1